Loading the session
Loading the session
Loading instrument
$16.70
+1.52%Delayed · Pre-marketDelayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 06:29 IST · A quote does not mean the product is available to trade on your account.
Opens 8:00 pm IST
Opens 8:00 pm IST
Opens 8:00 pm IST
In brief
Questions investors ask
Quotes run fifteen minutes behind.
1 month: −6.2% (SPY −1.6%, XLV +13.5%). 3 months: +9.5% (SPY −0.4%, XLV +15.5%). 1 year: +81.1% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: CYRX, SPY and XLV · as of 4 Nov 2026
3 Nov 2026 volume of 2.5M shares was 3.0× the average of the 30 sessions before it (824.1K), as the price rose 1.4%. SPY traded 0.8× its own average that session.
Daily volume against a 30-session baseline · as of 3 Nov 2026
The 4 Nov 2026 close of $16.70 was 1.4% below its 50-day average ($16.94) and 24.8% above its 200-day average ($13.38). It has closed above the 200-day for 149 sessions, since 6 Apr 2026. The 50-day average crossed above the 200-day on 8 May 2026, 124 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
Closed at $16.70 on 4 Nov 2026: 11.5% below the 52-week high of $18.88 (28 Oct 2026) and 119.4% above the low of $7.61 (3 Mar 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
2.5M shares were sold short at the 15 Oct 2026 settlement, 5.0% of the 50.6M shares outstanding; covering them would take 3.1 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Price return, split-adjusted
At the 4 Nov 2026 close
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.
March 11, 2025
+41.49%March 5, 2025
+30.63%November 4, 2022
−32.05%